Navigation Links
Reaching the Heart Through the Wrist
Date:8/18/2008

Though procedure is used less often, it reduces bleeding problems, study finds

MONDAY, Aug. 18 (HealthDay News) -- Threading a catheter into the heart from the wrist rather than the groin reduces the incidence of bleeding problems during angioplasty, a new study finds.

The approach, using the radial artery in the wrist, is not widely practiced in the United States, according to an analysis of almost 600,000 catheterizations in a national database, said a report in the August issue of the Journal of the American College of Cardiology.

"It's done in about 1.5 percent of all procedures in the U.S.," said study author Dr. Sunil V. Rao, director of the cardiac catheterization laboratory at the Durham VA Medical Center.

The study found that bleeding complications in angioplasties done through the femoral artery in the groin were twice as common as for the radial approach, with 1.83 percent of persons having the femoral approach suffering excess bleeding, compared to 0.79 percent with the radial approach. The angioplasty success rate was as high for the wrist method as for the groin approach.

The study also found that bleeding complications with the radial approach were less common in people at higher risk, such as the elderly and those with acute coronary syndromes.

In angioplasty, a balloon-tipped catheter is threaded into a blocked heart artery and is inflated to reopen the artery. In most cases, a stent, a flexible tube, is inserted to help keep the artery open.

"We need powerful blood techniques to help prevent restenosis," Rao said. "Bleeding is a major problem. The majority of bleeding problems are related to the access site, and a bleeding problem is related to long-term survival."

Rao said he uses the wrist artery for angioplasty in about 85 percent of his cases. He reserves the groin approach when it appears that using the wrist artery will compromise blood flow to
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Announcement Outlines 36 Month Custom Deployment Contract With Potential Revenues Reaching $30 Million Dollars
2. Reaching a Milestone: Project Smile Makes Local Charities and Patients Smile
3. Drug Treatment Market For Obesity Will Increase More Than Five-Fold, Reaching $2.7 Billion in 2016
4. Avalere Study Shows Medicare Part D Helping People with Type 2 Diabetes; Warns People with Diabetes of Probability of Reaching the Donut Hole
5. Penn scientists find a protein that inhibits Ebola from reaching out to infect neighboring cells
6. Blue Shield of California Reaching Out to Members Affected by California Storms
7. New method of drug delivery more effective at reaching brain tumors
8. Drug-Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U.S.
9. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
10. Air Pollution Can Damage Heart, Blood Vessels, Too
11. Infant Heart Transplant Controversy Continues
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Reaching the Heart Through the Wrist
Reaching the Heart Through the Wrist
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- ...d asthma can have bad reactions to certain holiday...ent sneezing and wheezing, according to the Americ...I). , Those who are allergic to live evergreens ma...oth live and artificial trees can trigger symptoms...
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
... its ReNu with MoistureLoc contact lens solution b...e associated with it. Now in a new study from Uni... show that these infections were fueled and made r...call this conglomeration of cells biofilms. , On...
...monitoring of biomarkers used by, physicians to he...ses and conditions, ...nnounced today the availability of the Biophysical... usually missed in,standard annual physicals. Thro...
...p Kids Receive Care, CHICAGO, Jan. 28 In honor o...ruary, the Wm. Wrigley Jr. Company,(NYSE: WWY ) i...oss sales in,the U.S. (up to another $100,000) of ... health education,screening and treatment services...
...mical Society (ACS) News Service Weekly PressPac w...emical & Engineering News.,Please credit the indiv...the source for this information. , ALL CONTENT IS...telepathy? A bizarre new property of DNA, Journal...
...ay led to spikes in blood sugar levels , ,...suggests the caffeine in those daily cups of java ...n a small group of 10 diabetics, glucose levels ro...e consumption -- and coffee is the most common sou...
...lletin,Board: NTRZ), a world leader in stabilized ... today provided an update on its domestic,operatio...ty located in Dillon,Montana has been running at f...is fully committed to run at full capacity,through...
Other Medicine News:Health News:New study finds resistant organisms at core of soft contact lens corneal infections 2Health News:Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre-Symptomatic Detection of Disease 2Health News:Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre-Symptomatic Detection of Disease 3Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 2Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 3Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 4Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 2Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 3Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 4Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 5Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 6Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 7Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 8Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 9Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 10Health News:Caffeine Could Spell Trouble for Diabetics 2Health News:NutraCea Provides Update on Domestic Operations 2Health News:NutraCea Provides Update on Domestic Operations 3
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)WILMINGTON, Del., Dec. 3 ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, will host a free webinar on Wednesday, Dec. 9, on the FDA,s dra
(Date:12/3/2009)FORT WORTH, Texas, Dec. 3 Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a rapidly growing provider of specialty medical products, announced today an agreement with the Health In
Breaking Medicine Technology:BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Centrix Pharmaceutical Announces Clofera 28TM 29 a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion 54520 1Centrix Pharmaceutical Announces Clofera 28TM 29 a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion 54520 2CordLife Makes Headway into China 54519 1CordLife Makes Headway into China 54519 2CordLife Makes Headway into China 54519 3CordLife Makes Headway into China 54519 4CordLife Makes Headway into China 54519 5Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 1Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 2Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 3
...ration Oxazolidinone Enrolls in Four Months , , ... announced the completion of enrollment in its ran...ng the oral dosage form of torezolid (also known a...in structure infections (cSSSI). The trial, which...States, examined the efficacy and safety of three ...
.... 23 Today the FDA announced,approval for the fir...Cells,but Adult Stem Cell scientist Christian Drap...story; Adult Stem Cells have greater potential wit...xciting step forward toward freeing science,from t...t commentary we,re,seeing surrounding the FDA,s ac...
Other Medicine Technology:Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections 2FDA Stem Cell Approval Breakthrough Laudable 2
...e HF-compatible V series from Pentax, the standard...ed., ,The HF-compatible series of fibre bronchosc...d FB-15V models along with the very slim FB-10V an...lity thanks mainly to the higher resolution and wi...
BRO-YP2 Pediatric Bronchoscope
OES BF-40 Bronchoscope
...ofiberscopes with electrosurgical capability, has ...nd for expanded bronchoscopic diagnostic and treat...l section and ergonomic design to facilitate incre...eld of view, a smaller insertion tube and distal e...
Medicine Products: